Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000164691 | SCV000215358 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-07-24 | criteria provided, single submitter | clinical testing | The p.T1238S variant (also known as c.3713C>G), located in coding exon 8 of the MSH6 gene, results from a C to G substitution at nucleotide position 3713. The threonine at codon 1238 is replaced by serine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV000458549 | SCV000551205 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2024-09-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000485750 | SCV000565234 | uncertain significance | not provided | 2024-11-13 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 17531815, 21120944) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003226225 | SCV003922557 | uncertain significance | not specified | 2023-03-10 | criteria provided, single submitter | clinical testing |